A number of research firms have changed their ratings and price targets for Healthcare Realty Trust (NYSE: HR):

  • 10/2/2017 – Healthcare Realty Trust had its “buy” rating reaffirmed by analysts at BMO Capital Markets. They now have a $34.00 price target on the stock.
  • 9/26/2017 – Healthcare Realty Trust had its “sell” rating reaffirmed by analysts at KeyCorp. They now have a $25.00 price target on the stock.
  • 9/25/2017 – Healthcare Realty Trust had its price target raised by analysts at Morgan Stanley from $32.50 to $34.00. They now have an “overweight” rating on the stock.
  • 9/25/2017 – Healthcare Realty Trust was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Healthcare Realty Trust is a real estate investment trust that integrates owning, managing and developing income-producing real estate properties associated with the delivery of healthcare services throughout the United States. “
  • 9/13/2017 – Healthcare Realty Trust was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Healthcare Realty Trust is a real estate investment trust that integrates owning, managing and developing income-producing real estate properties associated with the delivery of healthcare services throughout the United States. “
  • 8/24/2017 – Healthcare Realty Trust had its “sell” rating reaffirmed by analysts at KeyCorp. They now have a $25.00 price target on the stock.
  • 8/23/2017 – Healthcare Realty Trust had its “buy” rating reaffirmed by analysts at Cantor Fitzgerald. They wrote, “Lowering 2017-18 normalized FFO estimates. Our revised normalized FFO estimates are $1.59 per share for 2017 (vs. our prior $1.60 estimate and the $1.60 Bloomberg consensus) and $1.66 for 2018 (vs. prior $1.80 and $1.73 consensus). Our normalized AFFO estimates are $1.36 per share for 2017 (vs. the $1.33 consensus) and $1.46 for 2018 (in line with the consensus). Large dispositions. We believe that HR will divest seven properties in Virginia (through the exercise of a tenant purchase option) in 1Q18. We expect proceeds of approximately $45 million and a reduction in 2018 NOI of about $4.5 million before the redeployment of the proceeds. These are legacy properties dating to the Capstone acquisition nearly 20 years ago (1998), and the cap rate is more than twice what we believe that HR can realize when it redeploys the proceeds.””
  • 8/19/2017 – Healthcare Realty Trust was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 8/15/2017 – Healthcare Realty Trust had its “buy” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $38.00 price target on the stock. They wrote, “2017-18 Outlook. Our normalized FFO estimates are $1.60 per share in 2017 (unchanged) and $1.80 in 2018 (vs. prior $1.75). We are making limited changes to our normalized FFO estimates, despite last week’s equity offering, and estimate that the pending Atlanta deal could add $30 million of rent and push up 2018 a nickel relative to our former FFO estimate. Increased divestitures in 1H17 and the 4Q16 sale of three IRFs diluted 1Q17 FFO by $0.01 and 2Q17 by $0.02, but we expect the proceeds to be reinvested by the end of this year.””

Shares of Healthcare Realty Trust Incorporated (NYSE HR) traded down 0.34% during trading on Wednesday, reaching $31.94. 1,020,451 shares of the company traded hands. The company has a 50 day moving average price of $32.98 and a 200 day moving average price of $33.26. The firm has a market capitalization of $3.72 billion, a price-to-earnings ratio of 30.71 and a beta of 0.31. Healthcare Realty Trust Incorporated has a 12-month low of $26.66 and a 12-month high of $36.25.

Healthcare Realty Trust (NYSE:HR) last posted its earnings results on Wednesday, August 2nd. The real estate investment trust reported $0.39 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.01). Healthcare Realty Trust had a return on equity of 7.38% and a net margin of 28.98%. The business had revenue of $105.20 million for the quarter, compared to analyst estimates of $105.67 million. During the same quarter in the prior year, the business earned $0.42 earnings per share. The firm’s quarterly revenue was up 2.5% on a year-over-year basis. On average, equities analysts predict that Healthcare Realty Trust Incorporated will post $0.70 EPS for the current year.

In other news, Director John Knox Singleton purchased 3,450 shares of the company’s stock in a transaction dated Tuesday, August 15th. The shares were purchased at an average price of $31.88 per share, for a total transaction of $109,986.00. Following the transaction, the director now owns 17,693 shares of the company’s stock, valued at $564,052.84. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 1.85% of the stock is owned by company insiders.

Healthcare Realty Trust Incorporated is a self-managed and self-administered real estate investment trust. The Company owns, leases, manages, acquires, finances, develops and redevelops real estate properties associated primarily with the delivery of outpatient healthcare services across the United States.

Receive News & Ratings for Healthcare Realty Trust Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.